Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
35 /100
COMPONENT-LIMITED
Score updated Oct 27, 2026

OTLC — Oncotelic Therapeutics, Inc. Dilution Risk Tracker

Track OTLC dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track OTLC — Get alerts when the score changes →

As of October 27, 2026, Oncotelic Therapeutics, Inc. (OTLC) has a DilutionWatch DilutionScore of 35/100, rated MEDIUM dilution risk. This is a component-limited score because one or more material inputs are unavailable or not applicable. Oncotelic Therapeutics, Inc. has a market capitalization of $7.78M, 457.51M shares outstanding. Stored dilution-related fields include 60.84M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
10
📊Float Risk—
⚠️ Warrant Exposure
50
🔄 Convertible Debt
15

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 32%
🔄 Reverse Split model est. 55%
• 50-day avg $0.04 below $1 exchange minimum
📜 Warrant Exercise model 15%
• Warrant overhang: 13.3% of shares outstanding
🔔 Track OTLC — Get forecast alerts →

Market Data

Market Cap$7.78M
Shares Outstanding457.51M
FloatN/A
Cash$2.71M
Debt$2.72M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore35/100DilutionWatch score record
Shares Outstanding457.51MVerified float table or market cache
Public FloatNot availableVerified float table or market cache
Market Cap$7.78MMarket data cache
Cash Runway32.8 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants60.84MSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 2.

Recent SEC source mix: XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

OTLC SEC Filing Activity — Last 12 Months

Shares outstanding reported by OTLC on the cover page of its latest 10-K/10-Q: 457.51M as of August 13, 2026.

DilutionWatch recorded no shelf, registration or prospectus documents for OTLC in the last 12 months. Full filing list on SEC EDGAR →

FormWhat it isFilingsMost recent
8-Kcurrent report (material event)9Oct 26, 2026
10-Kannual report2Apr 15, 2026
10-Qquarterly report2Aug 13, 2026
5annual insider ownership9Jul 23, 2026

Institutional Holdings

Institutional data not yet available.

Short Interest

Short Interest229.1K
Days to Cover1.0
% of FloatN/A
FINRA data as of Oct 15, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-08-13
xbrl XBRL CONVERTIBLE 2026-04-15
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual OTLC Dilution Snapshot

Oncotelic Therapeutics, Inc. (OTLC) has a DilutionScore of 35/100, rated Medium dilution risk. Score date: October 27, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

OTLC's DilutionScore is currently 35/100 (Medium risk), with 3 score changes tracked over 89 days. The score improved from 29/100 (Medium risk).

Period Score Risk Level Duration
Oct 01 – Oct 27, 202635/100MEDIUM27 days
Aug 22 – Sep 30, 202629/100MEDIUM40 days
Aug 14 – Aug 21, 202633/100MEDIUM7 days
Jul 30 – Aug 13, 202626/100MEDIUM15 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

OTLC shares outstanding have increased 0.6% from 441.58M (Mar 2026) to 444.20M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 16, 2026444.20M228.27M▼ 0.15%
Apr 23, 2026444.20M228.62M▲ 0.22%
Apr 21, 2026444.20M228.13M▲ 0.67%
Mar 05, 2026441.58M226.37M▲ 0.34%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track OTLC Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment OTLC files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking OTLC — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,566+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

Score Coverage Note